| 
			 Apple shares rose 1.2 percent to $114.18, another record high. The 
			stock lifted the Nasdaq, which outperformed other indexes. 
 Biotech stocks were among biggest decliners in the S&P health care 
			index, which fell 0.8 percent and was the biggest drag on the S&P 
			500. Gilead fell 2.1 percent to $102.06, while Biogen Idec lost 3.9 
			percent to $305.43 and was the biggest percentage decliner on both 
			the S&P 500 and Nasdaq.
 
 The Nasdaq biotech index shed 2 percent, its biggest drop in about a 
			month.
 
 Energy stocks rose 0.8 percent following a bounceback in oil prices.
 
			
			 
			Also helping to limit the day's losses was a stronger-than-expected 
			rise in October retail sales.
 The S&P 500, which hasn't made a 1 percent move this month, is now 
			up 10.4 percent for the year.
 
 "Most portfolio managers are lagging the indices and there are going 
			to be some aggressive efforts to make up for performance in the next 
			six weeks. Those that are under invested are going to want to be 
			more invested," said Michael James, managing director of equity 
			trading at Wedbush Securities in Los Angeles.
 
 "The market will either tread water or move higher from here to the 
			end of the year" barring a huge drop in oil prices, he said.
 
 The Dow Jones industrial average fell 18.05 points, or 0.1 percent, 
			to 17,634.74, the S&P 500 gained 0.49 points, or 0.02 percent, to 
			2,039.82 and the Nasdaq Composite added 8.40 points, or 0.18 
			percent, to 4,688.54.
 
 [to top of second column]
 | 
            
 
			For the week, the Dow and S&P 500 rose 0.4 percent and the Nasdaq 
			climbed 1.2 percent.
 Shares of Hertz Global Holdings fell 4.6 percent to $21.69 after it 
			said it would restate 2012 and 2013 financial results.
 
 Shares of low-cost airline Virgin America Inc soared 30.4 percent in 
			their market debut.
 
 Volume was again light. About 6 billion shares changed hands on U.S. 
			exchanges, below the 6.5 billion average this month, according to 
			BATS Global Markets. NYSE advancers outnumbered decliners 1,618 to 
			1,452, for a 1.11-to-1 ratio on the upside; on the Nasdaq, 1,380 
			issues fell and 1,309 advanced for a 1.05-to-1 ratio favoring 
			decliners. The S&P 500 posted 27 new 52-week highs and four new 
			lows; the Nasdaq Composite recorded 65 new highs and 53 new lows.
 
 (Additional reporting by Chuck Mikolajczak; Editing by Nick 
			Zieminski)
 
			[© 2014 Thomson Reuters. All rights 
				reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 
			
			 |